Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up.

C, Amadou; S, Franc; PY, Benhamou; S, Lablanche; E, Huneker; G, Charpentier; A, Penfornis

doi:10.2337/dc20-1809

Public

Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up.

Shared by NobleBlocks on Jan 11, 2021 • 12:00 AM UTC

Authors:

Amadou C

Franc S

Benhamou PY

Abstract

Objective To analyze safety and efficacy of the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas system in patients with type 1 diabetes in real-world conditions.Research design and methods After a 1-week run-in period with their usual pump, 25 patients were provided the commerc...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!